Prof Dr med Göran Hajak
Sozialstiftung Bamberg – Klinikum am Michelsberg, Germany
Göran Hajak is Professor of Psychiatry at the University of Regensburg, Germany and Director of the Department of Psychiatry, Psychosomatic Medicine and Psychotherapy at the Social Foundation Bamberg, teaching hospital of the University of Erlangen, Germany.
Dr. Hajak is Medical Board certified for Neurology, Psychiatry, Psychotherapy, Sleep Medicine, and Traffic Medicine, and holds an Master of Business Administration degree in Health Management.
His widespread interests include research in the areas of effective, emotional, psychotic, somatoform, and sleep disorders, the mechanisms of neuroplasticity and brain networking, psychopharmacology, and health management.
His work has qualified him to be named in the Who-is-Who-List of Medicine Germany and the Focus TOP-100-List of Medical Doctors in Germany as a distinguished physician for the treatment of Depression, Bipolar Disorders, Schizophrenia and Anxiety Disorders.
Dr Hajak has authored or co-authored 386 peer-reviewed original papers and 210 review articles with an accumulated impact factor of 1130, 131 book chapters, 22 books, and more than 800 abstracts (January 2019).
Prof Stefano Pallanti
Istituto di Neuroscienze del Prof. Stefano Pallanti, Italy
Dr Stefano Pallanti is Professor of Psychiatry at the University of Florence, Director of the Institute for Neurosciences in Italy, creating and chairing a TMS Clinical service for “Treatment Resistant” patients. He is Professor of Psychiatry and Behavioral Sciences at Stanford University Medical Center, Stanford, CA, USA, where he works as TMS Consultant, Visiting Professor at Albert Einstein College of Medicine, New York, USA, Visiting Professor at Imperial College, London, UK and Adjunct Associate Professor at Icahn School of Medicine at Mount Sinai, New York, USA, where he served as the Founder and Director of the Strategic Center of Excellence for OCD, Impulsive and Behavioural Addiction.
He is currently a co-PI (principal investigator) for 2017 – 2019 conducting the National Institute of Mental Health R21 Grant “Modulating Inhibitory Control Networks in Gambling Disorder with Theta Burst Stimulation”. He has previously been a PI and co-PI of over ten studies, most of which were multicenter or international producing peer-reviewed publications from each project.
Dr Pallanti is a founder, member of the Clinical TMS Society (USA) where he served as a member of the board of Directors from 2013 to 2017. He is an Executive Committee Member, Fellow Member and the Scientific Board of ECNP (European College of Neuropsychopharmacology) and serves in its Educational Committee. He is the Advisory Council of the International Center for Autism Research and Education (Icare4autism, New York), a Fellow and the International Advisory Board of the American Psychiatric Association for the Diagnostic and Statistical Manual of Mental Disorders, for its Fourth Edition (DSM-IV) and the Obsessive Compulsive Disorder Spectrum Workgroup for the DSM-5.0.
He is a member of the board of directors of the International College for Obsessive-Compulsive Spectrum Disorders (ICOCS) and an Associate Director of the European Certificate, International Master Course in Affective Neuroscience. Dr. Pallanti is a member of the New York Society of Psychiatry and an International fellow member of American Psychiatric Association.
In 2019 Dr Pallanti is appointed a faculty and speaker of the International Psychopharmacology Course of the Harvard University and Massachusetts General Hospital Psychiatry Academy and of the Training School at Clare College, Cambridge University, UK for the European Network for Problematic Usage of the Internet.
He is particularly active in rTMS, Neuromodulation, Photo-Bio Modulation covering a broad area of Neuro Psychiatry. He is Editor of Archive of Behavioral Addiction, Deputy Editor of CNS Spectrums, where he is also a columnist. He has published more than 183 peer reviewed papers, 12 books, 4 manuals of Psychiatry and his H index is 51 as of January 2019.